Yiyi Wang Selected Research

Yiyi Wang Research Topics

Disease

3	Brain Ischemia (Cerebral Ischemia) 01/2016 - 10/2011
2	Infections 06/2022 - 09/2015
2	Pain (Aches) 03/2022 - 02/2016
2	Endometriosis 03/2022 - 02/2021
2	Hypertension (High Blood Pressure) 08/2021 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 01/2013
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 06/2014
1	Melanoma (Melanoma, Malignant) 06/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022
1	Tuberculosis (Tuberculoses) 06/2022
1	Pemphigus (Pemphigus Vulgaris) 04/2022
1	Leukopenia 04/2022
1	Chronic Pain 03/2022
1	Guillain-Barre Syndrome 01/2022
1	Postherpetic Neuralgia 01/2022
1	Arthralgia (Joint Pain) 08/2021
1	Anorexia 04/2021
1	Fatty Liver 03/2021
1	Adenomyosis 03/2021
1	Fibrosis (Cirrhosis) 03/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Burns 01/2021
1	Hemophilia B (Haemophilia B) 11/2020
1	Hemorrhage 11/2020
1	1 Combined Deficiency Of Vitamin K-Dependent Clotting Factors 08/2020
1	Genomic Instability 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 05/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2018
1	Hepatocellular Carcinoma (Hepatoma) 11/2016
1	Inflammation (Inflammations) 02/2016
1	Central Nervous System Vasculitis 09/2015
1	Ischemic Stroke 06/2012
1	Mental Disorders (Mental Disorder) 02/2012

Drug/Important Bio-Agent (IBA)

2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2022 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 03/2021
2	C-Reactive ProteinIBA 08/2021 - 03/2021
2	Vitamin K FDA Link 11/2020 - 08/2020
2	hydroxysafflor yellow AIBA 01/2016 - 06/2014
1	LigandsIBA 06/2022
1	Monoclonal AntibodiesIBA 06/2022
1	Immune Checkpoint InhibitorsIBA 06/2022
1	Programmed Cell Death 1 ReceptorIBA 06/2022
1	secukinumabIBA 06/2022
1	Adalimumab (Humira)FDA Link 06/2022
1	Diphosphates (Pyrophosphates)IBA 04/2022
1	2-mercaptopurineIBA 04/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2022
1	Prednisone (Sone)FDA LinkGeneric 04/2022
1	Desmoglein 1IBA 04/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2022
1	AutoantibodiesIBA 04/2022
1	Azathioprine (Imuran)FDA LinkGeneric 04/2022
1	NucleosidesIBA 04/2022
1	Hemoglobins (Hemoglobin)IBA 04/2022
1	Collagen Type I (Type I Collagen)IBA 03/2021
1	Connective Tissue Growth FactorIBA 03/2021
1	CollagenIBA 03/2021
1	UbiquitinIBA 02/2021
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	protoporphyrin IXIBA 01/2021
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2020
1	Protein Sorting Signals (Signal Peptide)IBA 11/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 08/2020
1	DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)IBA 01/2020
1	ArsenicIBA 01/2020
1	VaccinesIBA 01/2020
1	DNA Repair EnzymesIBA 01/2020
1	Drinking WaterIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2019
1	OzoneIBA 09/2018
1	Particulate MatterIBA 09/2018
1	Air Pollutants (Pollutants, Air)IBA 09/2018
1	Ethanol (Ethyl Alcohol)IBA 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	Therapeutic UsesIBA 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	monomethoxypolyethylene glycol (MPEG)IBA 01/2013
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2013
1	human ERBB2 proteinIBA 01/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	ChitosanIBA 01/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2013
1	Glial Fibrillary Acidic ProteinIBA 06/2012
1	3-n-butylphthalide (butylphthalide)IBA 06/2012
1	Pharmaceutical PreparationsIBA 02/2012
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2011

Therapy/Procedure

2	Therapeutics 06/2022 - 06/2012
1	Immunotherapy 06/2022
1	Duration of Therapy 06/2022
1	Electroacupuncture 01/2022
1	Massage (Zone Therapy) 04/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Oral Administration 11/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2016